copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
THL Key Takeaways: In August 2025, THL announced a majority investment in Headlands Research, a leading North American network of clinical trial sites that partners directly with pharmaceutical sponsors and CROs to advance medical research and help bring new therapies to market
Who we are - THL Our dedicated THL team is here to support our portfolio company partners With deep expertise across both our specialized ISOs and key operating areas, we strive to help great companies achieve their fullest potential
Portfolio - THL Our dedicated THL team is here to support our portfolio company partners With deep expertise across both our specialized ISOs and key operating areas, we strive to help great companies achieve their fullest potential
Team - THL From veteran investment and operating professionals to dedicated support staff and an extended network of executive advisors, our team is driven by a relentless focus on building great companies of lasting value This shared passion is what enables us to break new ground and create enduring partnerships alongside management teams around the world
Life at THL - THL Casting a wide net for the strongest talent, and making THL a place where people can build successful careers, help ensure the firm’s long-term, sustainable success
How we invest - THL At THL, we apply an integrated private equity model that breaks down traditional silos to create teams of senior investment and operating professionals, and executive partners—each with years of deep sector experience and relationships across our focus areas
Automation - THL We believe we are the first private equity firm with a fund dedicated to automation, THL supports management teams with extensive experience, relationships and resources focused on our automation franchise
GrowthCap Top Private Equity Firms of 2025 - THL The award was given on 8 19 25 After being notified by GrowthCap of THL’s selection for the award, THL paid a fee to secure award receipt In general, the receipt of compensation influences, and is likely to present a potential material conflict of interest, relating to any granted award
John L. Russo - THL Before joining the THL team, John was a Senior Associate of Compliance Consulting with Kroll, LLC where he focused on regulatory filings, forms and annual reviews and ongoing monitoring of clients’ compliance programs
Pharma Services - THL Key Takeaways: In August 2025, THL announced a majority investment in Headlands Research, a leading North American network of clinical trial sites that partners directly with pharmaceutical sponsors and CROs to advance medical research and help bring new therapies to market